Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database
Hoisnard L, Lebrun-Vignes B, Maury S, Mahevas M, El Karoui K, Roy L, Zarour A, Michel M, Cohen JL, Amiot A, Claudepierre P, Wolkenstein P, Grimbert P, Sbidian E.
Sci Rep. 2022 May 3;12(1):7140.
doi: 10.1038/s41598-022-10777-w. PMID: 35504889 Free PMC article.
Face involvement is reflective of global perception of extent in vitiligo patients
Merhi S, Salameh P, Abboud M, Eleftheriadou V, Pane I, Tran VT, Shourick J, Ezzedine K.
Br J Dermatol. 2023 Apr 1:ljad109.
doi: 10.1093/bjd/ljad109. Online ahead of print. PMID: 37002778.
Reality of drug-induced erythema multiforme: A French pharmacovigilance study
Demouche S, Bettuzzi T, Sbidian E, Laugier Castellan D, Osmont MN, Ingen-Housz-Oro S, Lebrun-Vignes B.
Therapie. 2023 Mar 10:S0040-5957(23)00052-5.
doi: 10.1016/j.therap.2023.03.004. Online ahead of print. PMID: 37024401.
First-line persistence of biologics in psoriasis from a cohort based on French medico-administrative data
Marcombes C, Penso L, Sbidian E.
J Invest Dermatol. 2023 Mar 28:S0022-202X(23)01944-9.
doi: 10.1016/j.jid.2023.03.1660. Online ahead of print. PMID: 36997111 No abstract available.
Has the core outcome (domain) set for vitiligo been implemented? An updated systematic review on outcomes and outcome measures in vitiligo randomized clinical trials
Eleftheriadou V, Bergqvist C, Kechichian E, Shourick J, Ju HJ, van Geel N, Bae JM, Ezzedine K.
Br J Dermatol. 2023 Feb 10;188(2):247-258.
doi: 10.1093/bjd/ljac074. PMID: 36763863.
Long-term persistence of second-line biologics in psoriatic arthritis patients with prior TNF inhibitor exposure: a nationwide cohort study from the French health insurance database (SNDS)
Pina Vegas L, Hoisnard L, Bastard L, Sbidian E, Claudepierre P.
RMD Open. 2022 Dec;8(2):e002681.
doi: 10.1136/rmdopen-2022-002681. PMID: 36597983 Free PMC article.
Placebo response in moderate-to-severe psoriasis: prevalence meta-analysis of randomised controlled trials
Afach S, Le Cleach L, Sbidian E.J Invest Dermatol.
2022 Dec 20:S0022-202X(22)02892-5.
doi: 10.1016/j.jid.2022.10.024. Online ahead of print. PMID: 36563778.
Head-to-head trials in psoriasis and psoriatic arthritis: how to conclude?
Sbidian E, Pina-Vegas L.
Br J Dermatol. 2021 Dec;185(6):1085.
doi: 10.1111/bjd.20771. Epub 2021 Oct 20. PMID: 34668197 No abstract available.
Safety and efficacy of high-dose clobetasol propionate 0.05% in cutaneous lichen planus
Melin A, Bouchereau S, Guelimi R, Bergqvist C, Condamina M, Giraud-Kerleroux L, Hirsch G, Hua C, Wolkenstein P, Skayem C, Le Cleach L.
J Dermatol. 2022 Dec 28.
doi: 10.1111/1346-8138.16689. Online ahead of print. PMID: 36578108.
TNF-alpha inhibitors biosimilar use in France: a nationwide population-based study using the French National Health Data System
Jourdain H, Hoisnard L, Sbidian E, Zureik M.
Sci Rep. 2022 Nov 15;12(1):19569.
doi: 10.1038/s41598-022-24050-7. PMID: 36380105 Free PMC article.
Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: A randomized phase 2b clinical trial
Ezzedine K, Peeva E, Yamaguchi Y, Cox LA, Banerjee A, Han G, Hamzavi I, Ganesan AK, Picardo M, Thaçi D,
Harris JE, Bae JM, Tsukamoto K, Sinclair R, Pandya AG, Sloan A, Yu D, Gandhi K, Vincent MS, King B.
J Am Acad Dermatol. 2022 Nov 9:S0190-9622(22)02989-9.
doi: 10.1016/j.jaad.2022.11.005. Online ahead of print. PMID: 36370907.
Paradoxical reactions and biologic agents: a French cohort study of 9 303 patients
Bataille P, Layese R, Claudepierre P, Paris N, Dubiel J, Amiot A, Sbidian E.
AP-HP/Universities/Inserm COVID-19 research collaboration and on behalf of the ‘Entrepôt de Données de Santé’
AP-HP consortium.
Br J Dermatol. 2022 Nov;187(5):676-683.
doi: 10.1111/bjd.21716. Epub 2022 Jul 12. PMID: 35770735.
Erratum to "2022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritis"
Wendling D, Hecquet S, Fogel O, Letarouilly JG, Verhoeven F, Pham T, Prati C, Molto A, Goupille P, Dernis E, Saraux A, Ruyssen-Witrand A, Lukas C, Miceli-Richard C, Hudry C, Richette P, Breban M, Gossec L, Dougados M, Claudepierre P.
Joint Bone Spine. 2022 Oct;89(5):105428.
doi: 10.1016/j.jbspin.2022.105428. Epub 2022 Jul 1. PMID: 35785607 No abstract available.
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo
Rosmarin D, Passeron T, Pandya AG, Grimes P, Harris JE, Desai SR, Lebwohl M, Ruer-Mulard M, Seneschal J, Wolkerstorfer A, Kornacki D, Sun K, Butler K, Ezzedine K.
TRuE-V Study Group. N Engl J Med. 2022 Oct 20;387(16):1445-1455.
doi: 10.1056/NEJMoa2118828.
CITY-PSO: Prescribing behaviour of French private-practice dermatologists in psoriasis management: An observational, multicentre, cross-sectional study
Amici JM, Bergqvist C, Ly S, Corgibet F, Seï JF, Seneschal J, Sbidian E, Beylot-Barry M.
Ann Dermatol Venereol. 2022 Sep;149(3):169-175.
doi: 10.1016/j.annder.2022.01.001. Epub 2022 Feb 15. PMID: 35181154.
Patterns of Medication Errors Involving Older Adults Reported to the French Medication Error Guichet
Azar C, Thomas L, Gras-Champel V, Laroche ML, Grau M, Allué D, Saleh N, Maison P.
J Patient Saf. 2022 Mar 1;18(2):e514-e521.
doi: 10.1097/PTS.0000000000000859. PMID: 34009874.
Patient Unique Stigmatization Holistic tool in dermatology (PUSH-D): Development and validation of a dermatology-specific stigmatization assessment tool
Ezzedine K, Shourick J, Bergqvist C, Misery L, Chuberre B, Kerob D, Halioua B, Le Fur G, Paul C, Richard MA, Taieb C.
J EurAcad Dermatol Venereol. 2022 Oct 6.
doi: 10.1111/jdv.18641. Online ahead of print. PMID: 36201355.
Risk of major adverse cardiovascular and venous thromboembolism events in patients with rheumatoid arthritis exposed to JAK inhibitors versus adalimumab: a nationwide cohort study
Hoisnard L, Pina Vegas L, Dray-Spira R, Weill A, Zureik M, Sbidian E.
Ann Rheum Dis. 2022 Oct 5:annrheumdis-2022-222824.
doi: 10.1136/ard-2022-222824. Online ahead of print. PMID: 36198438.
Unequal Behaviour between Hydrolysable Functions of Nirmatrelvir under Stress Conditions: Structural and Theoretical Approaches in Support of Preformulation Studies
Secretan PH, Annereau M, Kini-Matondo W, Prost B, Prudhomme J, Bournane L, Paul M, Yagoubi N,
Sadou-Yayé H, Do B.
Pharmaceutics. 2022 Aug 17;14(8):1720.
doi: 10.3390/pharmaceutics14081720. PMID: 36015346 Free PMC article.
Bullous pemphigoid: Three main clusters defining 3 outcome profiles
Guerrois F, Hassan E, Bettuzzi T, Seta V, Goulvestre C, Jelti L, Belmondo T, Wolkenstein P, Aractingi S,
Ingen-Housz-Oro S, Dupin N.
J Am Acad Dermatol. 2022 Aug;87(2):359-365.
doi: 10.1016/j.jaad.2022.04.029. Epub 2022 Apr 26. PMID: 35483492.
Vitiligo International Task force for an Agreed List of core data (VITAL): study protocol of a vitiligo core outcome set (COS) and contextual factors for clinical trials, registries, and clinical practice
van Geel N, Hamzavi IH, Pandya AG, Wolkerstorfer A, Seneschal J, Garg A, Spuls P, Terwee CB, Mallett S, Speeckaert R, Meurant JM, Eleftheriadou V, Ezzedine K.
Trials. 2022 Jul 23;23(1):591.
doi: 10.1186/s13063-022-06497-1. PMID: 35871019 Free PMC article.
Switches between biologics in patients with moderate-to-severe psoriasis: results from the French cohort PSOBIOTEQ
Curmin R, Guillo S, De Rycke Y, Bachelez H, Beylot-Barry M, Beneton N, Chosidow O, Dupuy A, Joly P, Jullien D,
Richard MA, Viguier M, Sbidian E, Paul C, Mahé E, Tubach F.
PSOBIOTEQ Study Group. J EurAcad Dermatol Venereol. 2022 Nov;36(11):2101-2112.
doi: 10.1111/jdv.18409. Epub 2022 Jul 22. PMID: 35793473.
Feasibility study and evaluation of expert opinion on the semi-automated meta-analysis and the conventional meta-analysis
Ajiji P, Cottin J, Picot C, Uzunali A, Ripoche E, Cucherat M, Maison P.
Eur J Clin Pharmacol. 2022 Jul;78(7):1177-1184.
doi: 10.1007/s00228-022-03329-8. Epub 2022 May 3.PMID: 35501476.
Real-life impact of immunologic tests to predict relapse after treatment cessation in patients with bullous pemphigoid: A French multicenter retrospective study
Battesti G, Garcia C, Viguier M, Marchal V, Castel M, Joly P, Ledard AP, Konstantinou MP, Seta V, Cordel N,
Duvert-Lehembre S, Tancrède-Bohin E, Belmondo T, Ingen-Housz-Oro S, d'Incan M.
J Am Acad Dermatol. 2022 Jun;86(6):1293-1300.
doi: 10.1016/j.jaad.2022.01.016. Epub 2022 Jan 26. PMID: 35091001.
Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database
Hoisnard L, Lebrun-Vignes B, Maury S, Mahevas M, El Karoui K, Roy L, Zarour A, Michel M, Cohen JL,
Amiot A, Claudepierre P, Wolkenstein P, Grimbert P, Sbidian E.
Sci Rep. 2022 May 3;12(1):7140.
doi: 10.1038/s41598-022-10777-w. PMID: 35504889 Free PMC article.
Long-term Persistence of First-line Biologics for Patients With Psoriasis and Psoriatic Arthritis in the French Health Insurance Database
Pina Vegas L, Penso L, Claudepierre P, Sbidian E.
JAMA Dermatol. 2022 May 1;158(5):513-522.
doi: 10.1001/jamadermatol.2022.0364. PMID: 35319735.
2022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritis
Wendling D, Hecquet S, Fogel O, Letarouilly JG, Verhoeven F, Pham T, Prati C, Molto A, Goupille P, Dernis E, Saraux A, Ruyssen-Witrand A, Lukas C, Miceli-Richard C, Hudry C, Richette P, Breban M, Gossec L, Dougados M, Claudepierre P.
Joint Bone Spine. 2022 May;89(3):105344.
doi: 10.1016/j.jbspin.2022.105344. Epub 2022 Jan 14. PMID: 35038574.
Evolution of Drug Survival with Biological Agents and Apremilast Between 2012 and 2018 in Patients with Psoriasis from the PsoBioTeq Cohort
Thomas Bettuzzi, Hervé Bachelez, Marie Beylot-Barry, Hugo Arlégui, Carle Paul, Manuelle Viguier,
Emmanuel Mahé, Nathalie Beneton, Denis Jullien, Marie-Aleth Richard, Pascal Joly, Florence Tubach,
Alain Dupuy, Emilie Sbidian, Olivier Chosidow; PsoBioTeq study group
Acta Derm Venereol. 2022 Mar 8:102:adv00665.
doi: 10.2340/actadv.v101.566.
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
Sbidian E, Chaimani A, Garcia-Doval I, Doney L, Dressler C, Hua C, Hughes C, Naldi L, Afach S, Le Cleach L.
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535.
doi: 10.1002/14651858.CD011535.pub5.PMID: 35603936.
Vitiligo Treatment Impact score (VITs): development and validation of a vitiligo burden of treatment questionnaire using the ComPaRe Vitiligo e-cohort
Shourick J, Seneschal J, Andreu N, Meurant JM, Pane I, Ravaud P, Tran VT, Ezzedine K.
J EurAcad Dermatol Venereol. 2022 Feb;36(2):279-285.
doi: 10.1111/jdv.17742. Epub 2021 Nov 12. PMID: 34657353
Adverse events associated with dupilumab in the World Health Organization pharmacovigilance database
Bettuzzi T, Drucker A, Staumont-Sallé D, Bihan K, Lebrun-Vignes B, Sbidian E.
J Am Acad Dermatol. 2022 Feb;86(2):431-433.
doi: 10.1016/j.jaad.2021.09.050. Epub 2021 Sep 30. PMID: 34600034 No abstract available.
British Association of Dermatologist guidelines: a lighthouse to help guide clinicians and researchers planning future clinical trials for vitiligo
Ezzedine K, Pandya AG.
Br J Dermatol. 2022 Jan;186(1):3-4.
doi: 10.1111/bjd.20815. Epub 2021 Nov 2. PMID: 34726772 No abstract available.
Psoriasis-related treatment exposure and hospitalization or in-hospital mortality due to COVID-19 during the first and second wave of the pandemic: cohort study of 1 326 312 patients in France
Penso L, Dray-Spira R, Weill A, Zureik M, Sbidian E.
Br J Dermatol. 2022 Jan;186(1):59-68.
doi: 10.1111/bjd.20659. Epub 2021 Aug 31. PMID: 34310699 Free PMC article.
Quality of life measurement in vitiligo. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes with external experts
Chernyshov PV, Tomas-Aragones L, Manolache L, Pustisek N, Salavastru CM, Marron SE, Bewley A, Svensson A,
Poot F, Suru A, Salek SS, Augustin M, Szepietowski JС, Koumaki D, Katoulis AC, Sampogna F, Abeni D, Linder DM, Speeckaert R, van Geel N, Seneschal J, Ezzedine K, Finlay AY.
J EurAcad Dermatol Venereol. 2023 Jan;37(1):21-31.
doi: 10.1111/jdv.18593. Epub 2022 Oct 19. PMID: 36259656.
Evaluation of Thalidomide Treatment of Patients With Chronic Erythema Multiforme: A Multicenter Retrospective Cohort Study
Roux C, Sbidian E, Bouaziz JD, Kottler D, Joly P, Descamps V, Prost C, Samimi M, Seneschal J, Dupin N, Girard C,
Paul M, Le Cleach L, Ingen-Housz-Oro S.
JAMA Dermatol. 2021 Dec 1;157(12):1472-1476.
doi: 10.1001/jamadermatol.2021.4083. PMID: 34757396 Free PMC article.
Pityriasis lichenoides: a clinical and pathological case series of 49 patients with an emphasis on follow-up
Lupu J, Chosidow O, Wolkenstein P, Bergqvist C, Ortonne N, Ingen-Housz-Oro S.
Clin Exp Dermatol. 2021 Dec;46(8):1561-1566.
doi: 10.1111/ced.14818. Epub 2021 Aug 27. PMID: 34170558.
Association Between Biologics Use and Risk of Serious Infection in Patients With Psoriasis
Laetitia Penso, Rosemary Dray-Spira, Alain Weill, Laura Pina Vegas, Mahmoud Zureik, Emilie Sbidian
JAMA Dermatol. 2021 Sep 1;157(9):1056-1065.
doi: 10.1001/jamadermatol.2021.2599.
Treatment recommendations for patients with vitiligo during COVID-19
Rodrigues M, Pandya AG, Hamzavi I, Ezzedine K, Bekkenk MW, Harris JE.
Australas J Dermatol. 2021 Aug;62(3):e481-e482
doi: 10.1111/ajd.13610. Epub 2021 May 24. PMID: 34028796 Free PMC article. No abstract available.
Health-related quality of life in paediatric patients with vitiligo: a systematic review and meta-analysis
Nathalie J, Chang J, Ezzedine K, Rodrigues M.
J EurAcad Dermatol Venereol. 2021 Nov;35(11):e755-e756.
doi: 10.1111/jdv.17382. Epub 2021 Jul 23. PMID: 34013610 No abstract available.
Non-acral skin manifestations during the COVID-19 epidemic: COVIDSKIN study by the French Society of Dermatology
Guelimi R, Salle R, Dousset L, Assier H, Fourati S, Bhujoo Z, Barbarot S, Boulard C, Cazanave C, Colin A, Kostrzewa E,
Lesort C, Levy Roy A, Lombart F, Marco Bonnet J, Marty L, Monfort JB, Riffaud L, Samimi M, Tardieu M, Sbidian E, Wolkenstein P, Le Cleach L, Beylot-Barry M.
J EurAcad Dermatol Venereol. 2021 Sep;35(9):e539-e541.
doi: 10.1111/jdv.17322. Epub 2021 May 12. PMID: 33914975 Free PMC article. No abstract available.
Development of a shared decision-making tool in vitiligo: an international study
Shourick J, Ahmed M, Seneschal J, Passeron T, Andreux N, Qureshi A, Chow EY, Natella PA, Harris J, Tran VT, Ezzedine K.
Br J Dermatol. 2021 Oct;185(4):787-796.
doi: 10.1111/bjd.20137. Epub 2021 Jun 16. PMID: 33830502.
Drop in biological initiation for patients with psoriasis during the COVID-19 pandemic
Penso L, Dray-Spira R, Weill A, Zureik M, Sbidian E.
Br J Dermatol. 2021 Sep;185(3):671-673.
doi: 10.1111/bjd.20406. Epub 2021 Jun 14.PMID: 33894022 Free PMC article. No abstract available.
Psoriasis-related treatment exposure and hospitalization or in-hospital mortality due to COVID-19 during the first and second wave of the pandemic: cohort study of 1 326 312 patients in France
Penso L, Dray-Spira R, Weill A, Zureik M, Sbidian E.
Br J Dermatol. 2021 Jul 26.
doi: 10.1111/bjd.20659. Online ahead of print.PMID: 34310699.
Most randomized controlled trials forpsoriasis used placebo comparators despite the availability of effective treatments
Afach S, Evrenoglou T, Oubaya N, Cleach LL, Sbidian E.
J Clin Epidemiol 2021;133:72–9.
doi: 10.1016/j.jclinepi.2021.01.013. PMID: 33482295.
Quality and Reporting Completeness of Systematic Reviews and Meta-Analyses in Dermatology
Afach S, Smires S, Mazaud C, Phan C, Garcia Doval I, Boyle R, et al.
J Invest Dermatol 2021;141:64–71.
doi: 10.1016/j.jid.2020.05.109. PMID: 32603750.
Risk of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis initiating interleukin 17 inhibitors: a nationwide population-based study using the French national health data system
Penso L, Bergqvist C, Meyer A, Herlemont P, Weill A, Zureik M, Dray-Spira R, Sbidian E.
Arthritis Rheumatol. 2021 Jul 19.
doi: 10.1002/art.41923. Online ahead of print.PMID: 34279061.
Factors associated with remission at 5-year follow-up in recent onset axial spondyloarthritis: results from the DESIR cohort
Pina Vegas L, Sbidian E, Wendling D, Goupille P, Ferkal S, Le Corvoisier P, Ghaleh B, Luciani A, Claudepierre P.
Rheumatology (Oxford). 2021 Jul 16:keab565.
doi: 10.1093/rheumatology/keab565. Online ahead of print.PMID: 34270707.
Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study
Pina Vegas L, Le Corvoisier P, Penso L, Paul M, Sbidian E, Claudepierre P.
Rheumatology (Oxford). 2021 Jul 9:keab522.
doi: 10.1093/rheumatology/keab522. Online ahead of print.PMID: 34244706.
Efficacy and safety of treatments in cutaneous polyarteritis nodosa: A French observational retrospective study
Bettuzzi T, Jachiet M, Sbidian E, Frumholtz L, Cordoliani F, Mouthon L, Chasset F, Paule R, Bouaziz JD, Guillevin L,
Terrier B, Aractingi S, Dupin N, Régent A.
J Am Acad Dermatol. 2021 Jul 2:S0190-9622(21)02021-1.
doi: 10.1016/j.jaad.2021.06.872. Online ahead of print.PMID: 34224771.
Investigating the efficacy and safety of metronidazole during pregnancy; A systematic review and meta-analysisy
Ajiji P, Uzunali A, Ripoche E, Vittaz E, Vial T, Maison P.
Eur J Obstet Gynecol Reprod Biol X. 2021 May 14;11:100128.
doi: 10.1016/j.eurox.2021.100128. eCollection 2021 Jul.PMID: 34136799 Free PMC article. Review.
Patterns of Medication Errors Involving Older Adults Reported to the French Medication Error Guichet
Azar C, Thomas L, Gras-Champel V, Laroche ML, Grau M, Allué D, Saleh N, Maison P.
J Patient Saf. 2021 Apr 29.
doi: 10.1097/PTS.0000000000000859. Online ahead of print.PMID: 34009874.
Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19' by Konig et al. Long-term exposure to hydroxychloroquine or chloroquine and the risk of hospitalisation with COVID-19: a nationwide, observational cohort study in 54 873 exposed individuals and 155 689 matched unexposed individuals in France
Emilie Sbidian, Laetitia Penso , Philippe Herlemont, Jérémie Botton, Bérangère Baricault, Laura Semenzato,
Jérome Drouin, Alain Weill, Rosemay Dray-Spira, Mahmoud Zureik.
PMID: 32859610 DOI: 10.1136/annrheumdis-2020-218647.
Beyond the quality of life: A call for patients' own willingness to pay in chronic skin disease to assess psychosocial burden: A multi-center, cross-sectional prospective survey
Jung Min Bae, Jung Eun Kim, Ro Woo Lee, Hyun Jeong Ju, Ju Hee Han, Joo Hee Lee, Yu Ri Woo, Ji Hae Lee,
Chul Hwan Bang, Chul Jong Park, Khaled Ezzedine, Miri Kim.
PMID: 33022310 DOI: 10.1016/j.jaad.2020.09.088.
Factors associated with perceived-stress in patients of the vitiligo ComPaRe e-cohort
Condamina M, Shourick J, Seneschal J, Sbidian E, Andreu N, Pane I, Ravaud P, Tran VT, Ezzedine K.
J Am Acad Dermatol. 2021 Mar 5:S0190-9622(21)00506-5.
doi: 10.1016/j.jaad.2021.02.083. Online ahead of print. PMID: 33684495 No abstract available.
Relationship between Urban Green Spaces and Cancer: A Scoping Review
Porcherie M, Linn N, Le Gall AR, Thomas MF, Faure E, Rican S, Simos J, Cantoreggi N, Vaillant Z, Cambon L, Regnaux JP.
Int J Environ Res Public Health. 2021 Feb 11;18(4):1751.
doi: 10.3390/ijerph18041751. PMID: 33670207 Free PMC article. Review.
Efficacy and Safety of Tacrolimus 0.1% for the Treatment of Facial Vitiligo: A Multicenter Randomized, Double-Blinded, Vehicle-Controlled Study
Seneschal J, Duplaine A, Maillard H, Passeron T, Andreu N, Lassalle R, Favary C, Droitcourt C, Taïeb A, Ezzedine K.
J Invest Dermatol. 2021 Feb 4:S0022-202X(21)00077-4.
doi: 10.1016/j.jid.2020.12.028. Online ahead of print. PMID: 33549606.
First-Line Biologic Therapy and Obesity in Moderate-to-Severe Psoriasis: Results from the Prospective Multicenter Cohort Psobioteq
Assan F, Tubach F, Arlegui H, Viguier M, Beylot-Barry M, Dupuy A, Beneton N, Joly P, Jullien D, Mahé E, Paul C,
Richard MA, Bachelez H, Giboin C, Chosidow O, Sbidian E.
and Psobioteq. Dermatology. 2021 Feb 3:1-9.
doi: 10.1159/000513398. Online ahead of print. PMID: 33535213.
Epidemiologic study in a real-world analysis of patients with treatment for psoriasis in the French national health insurance database
Grodner C, Sbidian E, Weill A, Mezzarobba M.
J Eur Acad Dermatol Venereol. 2021 Feb;35(2):411-416.
doi: 10.1111/jdv.16566. Epub 2020 Jun 9. PMID: 32364321.
Structural changes in the sacroiliac joint on MRI and relationship to ASDAS inactive disease in axial spondyloarthritis: a 2-year study comparing treatment with etanercept in EMBARK to a contemporary control cohort in DESIR
Maksymowych WP, Claudepierre P, de Hooge M, Lambert RG, Landewé R, Molto A, van der Heijde D, Bukowski JF, Jones H, Pedersen R, Szumski A, Vlahos B, Dougados M.
Arthritis Res Ther. 2021 Jan 29;23(1):43.
doi: 10.1186/s13075-021-02428-8. PMID: 33514428 Free PMC article.
Baseline Characteristics of a National French E-Cohort of Hidradenitis Suppurativa in ComPaRe and Comparison with Other Large Hidradenitis Suppurativa Cohorts
Condamina M, Penso L, Tran VT, Hotz C, Guillem P, Villani AP, Perrot P, Bru MF, Jacquet E, Nassif A, Bachelez H,
Wolkenstein P, Beylot-Barry M, Richard MA, Ravaud P, Viguier M, Sbidian E.
Dermatology. 2021 Jan 27:1-11.
doi: 10.1159/000513447. Online ahead of print. PMID: 33503635.
Vitiligo: A focus on pathogenesis and its therapeutic implications
Bergqvist C, Ezzedine K. J Dermatol. 2021 Mar;48(3):252-270.
doi: 10.1111/1346-8138.15743. Epub 2021 Jan 6. PMID: 33404102 Review.
Epidemiologic study of patients with psoriatic arthritis in a real-world analysis: a cohort study of the French health insurance database
Pina Vegas L, Sbidian E, Penso L, Claudepierre P.
Rheumatology (Oxford). 2021 Mar 2;60(3):1243-1251.
doi: 10.1093/rheumatology/keaa448. PMID: 32911531.
Perceived clinical severity of atopic dermatitis in adolescents: Comparison between patients' and parents' evaluation
Ezzedine K, Shourick J, Merhand S, Sampogna F, Taieb C.
J Am Acad Dermatol. 2021 Jan;84(1):164-165.
doi: 10.1016/j.jaad.2020.04.037. Epub 2020 Apr 15. PMID: 32304709 No abstract available.
Validation of the arabic version of Dutch eating behavior questionnaire (DEBQ) and associated factors: A cross-sectional study in a sample of Lebanese adults
S.Merhi, R.Ghadieh, A.Aoun, B.Galusca, A.Farhat, M.Ibrahim, J.Doumit.
Clinical Nutrition.
doi.org/10.1016/j.clnesp.2020.09.603.
Data to be collected for an optimal management of axial spondyloarthritis in daily practice: Proposal from evidence-based and consensual approaches
Baillet A, Romand X, Pflimlin A, Dalecky M, Claudepierrec P, Flipo RM, Ruyssen-Witrand A, Gaudin P, Gossec L, Molto A, Lukas C, Pouplin S, Soubrier M, Wendling D, Fayet F, Hudry C, Senbel E, Schwartz M, Hacquard-Bouder C, Dougados M.
Joint Bone Spine. 2020 Oct;87(5):405-411.
doi: 10.1016/j.jbspin.2020.04.019. Epub 2020 May 16. PMID: 32428691.
Comparison of the In Vitro and Ex Vivo Permeation of Existing Topical Formulations Used in the Treatment of Facial Angiofibroma and Characterization of the Variations Observed
Le Guyader G, Do B, Vieillard V, Andrieux K, Paul M.
Pharmaceutics. 2020 Nov 7;12(11):1060.
doi: 10.3390/pharmaceutics12111060. PMID: 33171735 Free PMC article.
Adalimumab and myositis: A case report and review of the French and international Pharmacovigilance Databases
Gaboriau L, Davion JB, Combret S, Lebrun-Vignes B, Rocher F, Rouby F, Renaud F, Morell-Dubois S, Gautier S.
NeuromusculDisord. 2020 Nov;30(11):915-920.
doi: 10.1016/j.nmd.2020.09.026. Epub 2020 Sep 20. PMID: 33071068.
Which imaging outcomes for axSpA are most sensitive to change? A 5-Year analysis of The DESIR Cohort
Sepriano A, Ramiro S, van der Heijde D, Dougados M, Claudepierre P, Feydy A, Reijnierse M, Loeuille D, Landewé R.
Arthritis Care Res (Hoboken). 2020 Sep 25.
doi: 10.1002/acr.24459. Online ahead of print. PMID: 32976683.
Interventions for chronic palmoplantar pustulosis: abridged Cochrane systematic review and GRADE assessments
Obeid G, Do G, Kirby L, Hughes C, Sbidian E, Le Cleach L.
Br J Dermatol. 2020 Sep 22.
doi: 10.1111/bjd.19560. Online ahead of print. PMID: 32961599.
The Arabic Urticaria Activity Score and Chronic Urticaria Quality of Life Questionnaire: validation and correlations
Tawil S, Irani C, Kfoury R, Salameh P, Baiardini I, Weller K, Maurer M, Ezzedine K.
Int J Derm 2020; 59(8):893-901.
doi: 10.1111/ijd.15006. PMID: 32638368.
Pharmacists and Continuing Education: A Cross-sectional Observational Study of Value and Motivation
Tawil S, Hallit S, Sacre H, Hajj A, Salameh P.
Int J Pharm Pract 2020; 28(4):380-389.
doi: 10.1111/ijpp.12616. PMID: 32190941.
Lebanese pharmacists’ confidence and self-perceptions of computer literacy: Scale validation and correlates
Tawil S, Hallit S, Sacre H, Rahme C, Hajj A, Salameh P.
J Pharmaceut Policy Pract 2020;13(44):1-8.
doi.org/10.1186/s40545-020-00246-y. PMID: 32855813.
Vitiligo: Targeted Therapies Add Color to Disease Pathophysiology
Ezzedine K, Vance TM, Hamzavi IH, Qureshi AA.
J Invest Dermatol. 2020 Aug;140(8):1498-1500.
doi: 10.1016/j.jid.2020.01.033. PMID: 32709274.
Evaluation of the impact of a nurse-led program of systematic screening of comorbidities in patients with axial spondyloarthritis: The results of the COMEDSPA prospective, controlled, one year randomized trial
Molto A, Gossec L, Poiraudeau S, Claudepierre P, Soubrier M, Fayet F, Wendling D, Gaudin P, Dernis E, Guis S, Pouplin S, Ruyssen A, Chales G, Mariette X, Beauvais C, Combe B, Flipo RM, Richette P, Chary-Valckenaere I, Saraux A, Sibilia J, Schaeverbeke T, Dougados M.
Semin Arthritis Rheum. 2020 Aug;50(4):701-708.
doi: 10.1016/j.semarthrit.2020.05.012. Epub 2020 May 27. PMID: 32521324.
Proceeding Report of the Second Vitiligo International Symposium-November 9-10, 2018, Detroit, Michigan, USA
Lyons AB, Ghia D, Abdallah M, Abdel-Malek Z, Esmat S, Ezzedine K, Grimes P, Harris JE, Lui H, Manga P, Mi QS,
Pandya A, Parsad D, Passeron T, Picardo M, Seneschal J, Silpa-Archa N, Taieb A, Xiang F, Lim HW, Hamzavi IH.
Pigment Cell Melanoma Res. 2020 Jul;33(4):637-641.
doi: 10.1111/pcmr.12867. Epub 2020 Mar 11. PMID: 31984599 No abstract available.
Evolution of topical steroids consumption before and after initiation of systemic treatment in psoriasis: epidemiologic study in a real-world analysis of the French national health insurance database
Grodner C, Mezzarobba M, Weill A, Sbidian E.
J Eur Acad Dermatol Venereol. 2020 Jun;34(6):e259-e262.
doi: 10.1111/jdv.16238. Epub 2020 Mar 4. PMID: 31991503 No abstract available.
Persistence of treatment with conventional systemic agents for patients with psoriasis: a real-world analysis of 73 168 new users from the French National Health Insurance database
Bergqvist C, Mezzarobba M, Weill A, Sbidian E.
Br J Dermatol. 2020 Jun;182(6):1483-1484.
doi: 10.1111/bjd.18734. Epub 2019 Dec 25. PMID: 31758801 No abstract available.
Individual Burden of Psoriasis (I-BOP): Building and Validation of a New Scoring Tool for Patients with Psoriasis
Ezzedine K, Fougerousse AC, Aubert R, Monfort JB, Reguiaï Z, Shourick J, Taieb C, Maccari F.
Clin CosmetInvestig Dermatol. 2020 May 4;13:325-332.
doi: 10.2147/CCID.S249776. eCollection 2020. PMID: 32440185 Free PMC article.
Out-of-pocket expenditures in France to manage psoriasis in adult patients: results from an observational, cross-sectional, non-comparative, multicentre study
Richard MA, Paul C, De Pouvourville G, Jullien D, Mahe E, Bachelez H, Seneschal J, Misery L, Aubert R, Reguiai Z, Shourick J, Taieb C, Joly P, Ezzedine K.
J Eur Acad Dermatol Venereol. 2021 Apr;35(4):912-918.
doi: 10.1111/jdv.17000. Epub 2020 Dec 8. PMID: 33073410.
Evaluation of risk factors for insulin resistance: a cross sectional study among employees at a private university in Lebanon
Samar Merhi, Myriam Fahed, Maya G Abou Jaoudeh, Jocelyne Matar Bou Mosleh, Rachelle Ghadieh, Sibelle Al Hayek, Jessy E El Hayek Fares.
BMC endocrine disorders.
doi: 10.1186/s12902-020-00558-9. PMID: 32522257.
Patients’ Perceptions regarding Pharmacists’ Healthcare Services: The case of Lebanon Evaluation
Tawil S, Sacre H, Sili G, Salameh P.
JPPR 2020:1-7.
doi: 10.1002/jppr.1615 9.
Meta-analysis results do not reflect the real safety of biologics in psoriasis
Afach S, Chaimani A, Evrenoglou T, Penso L, Brouste E, Sbidian E, et al.
Br J Dermatol 2020.
doi: 10.1111/bjd.19244. PMID: 32446286.
Consumers’ exposure to claims on pre-packed bread: the case of a developing country, Lebanon. Nutrition & Food Science
Samar Merhi, Christelle Bou-Mitri, Lama Khnaisser, Mira Bou Ghanem, Jessy El-Hayek Fares, Jacqueline Doumit,
Antoine G. Farhat.
Ahead-of-print. 10.1108/NFS-08-2019-0273.
Persistence of apremilast in moderate-to-severe psoriasis: a real-world analysis of 14 147 apremilast- and methotrexate-naive patients in the French National Health Insurance database
Sbidian E, Billionnet C, Weill A, Maura G, Mezzarobba M.
Br J Dermatol. 2020 Mar;182(3):690-697.
doi: 10.1111/bjd.18047. Epub 2019 Jul 22. PMID: 31021438.
Associations of lumbar scoliosis with presentation of suspected early axial spondyloarthritis
Voirin-Hertz M, Carvajal Alegria G, Garrigues F, Simon A, Feydy A, Reijnierse M, van der Heijde D, Loeuille D, Claudepierre P, Marhadour T, Saraux A.
Semin Arthritis Rheum. 2020 Feb;50(1):48-53.
doi: 10.1016/j.semarthrit.2019.06.008. Epub 2019 Jun 13. PMID: 31277929.
Interventions for chronic palmoplantar pustulosis
Obeid G, Do G, Kirby L, Hughes C, Sbidian E, Le Cleach L.
Cochrane Database Syst Rev. 2020 Jan 20;1(1):CD011628.
doi: 10.1002/14651858.CD011628.pub2. PMID: 31958161 Free PMC article.
Spinal-pelvic orientation: potential effect on the diagnosis of spondyloarthritis
Carvajal Alegria G, Deloire L, Herbette M, Garrigues F, Gossec L, Simon A, Feydy A, Reijnierse M,
van der Heijde D, Loeuille D, Claudepierre P, Marhadour T, Saraux A.
Rheumatology (Oxford). 2020 Jan 1;59(1):84-89.
doi: 10.1093/rheumatology/kez240. PMID: 31236597.
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
Sbidian E, Chaimani A, Afach S, Doney L, Dressler C, Hua C, Mazaud C, Phan C, Hughes C, Riddle D,
Naldi L, Garcia-Doval I, Le Cleach L.
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535.
doi: 10.1002/14651858.CD011535.pub3. PMID: 31917873 Free PMC article.
Respiratory virus infection triggers acute psoriasis flares across different clinical subtypes and genetic backgrounds
Sbidian E, Madrange M, Viguier M, Salmona M, Duchatelet S, Hovnanian A, Smahi A, Le Goff J, Bachelez H.
Br J Dermatol. 2019 Dec;181(6):1304-1306.
doi: 10.1111/bjd.18203. Epub 2019 Aug 20. PMID: 31150103 Free PMC article. No abstract available.
Cross-cultural validation of a short-form of the Vitiligo Impact Patient scale (VIPs)
Ezzedine K, Ahmed M, Tovar-Garza A, Hajj C, Whitton M, Pandya A, Altalhab S, Seneschal J, Harris J, Taieb C.
J Am Acad Dermatol. 2019 Nov;81(5):1107-1114.
doi: 10.1016/j.jaad.2019.02.008. Epub 2019 Feb 11. PMID: 30763647.
PAPASH, PsAPASH and PASS autoinflammatory syndromes: phenotypic heterogeneity, common biological signature and response to immunosuppressive regimens
Gottlieb J, Madrange M, Gardair C, Sbidian E, Frazier A, Wolkenstein P, Hickman G, Schneider P, Baudry C,
Claudepierre P, Bertheau P, Richette P, Smahi A, Bachelez H.
Br J Dermatol. 2019 Oct;181(4):866-869.
doi: 10.1111/bjd.18003. Epub 2019 Jul 25.
Importance of out-of-pocket costs for adult patients with atopic dermatitis in France
Launois R, Ezzedine K, Cabout E, Reguai Z, Merrhand S, Heas S, Seneschal J, Misery L, Taieb C.
J Eur Acad Dermatol Venereol. 2019 Oct;33(10):1921-1927.
doi: 10.1111/jdv.15581. Epub 2019 Apr 10. PMID: 30887577.
Users of biologics in clinical practice: would they be eligible for phase III clinical studies? Cohort Study in the French Psoriasis Registry PSOBIOTEQ
Masson Regnault M, Castañeda-Sanabria J, Diep Tran MHT, Beylot-Barry M, Bachelez H, Beneton N, Chosidow O,
Dupuy A, Joly P, Jullien D, Mahé E, Richard MA, Viguier M, Tubach F, Sbidian E, Paul C.
PsoBioTeq Study Group. J Eur Acad Dermatol Venereol. 2020 Feb;34(2):293-300.
doi: 10.1111/jdv.15878. Epub 2019 Oct 17. PMID: 31419355 Clinical Trial.
Building a scale for measuring burden of hand eczema: BoHEM
Maccari F, Ezzedine K, Fougerousse AC, Mérhand S, Bordet C, Jacobzone C, Taieb C.
J Am Acad Dermatol. 2019 Jun;80(6):1784-1785.
doi: 10.1016/j.jaad.2018.12.036. Epub 2018 Dec 23. PMID: 30586614 No abstract available.
Ustekinumab for skin reactions associated with anti-tumor necrosis factor-α agents in patients with inflammatory bowel diseases: A single-center retrospective study
Ezzedine K, Visseaux L, Cadiot G, Brixi H, Bernard P, Reguiai Z.
J Dermatol. 2019 Apr;46(4):322-327.
doi: 10.1111/1346-8138.14816. Epub 2019 Feb 28. PMID: 30816581.
Attitudes of Lebanese pharmacists towards online and live continuing education sessions
Tawil S, Sacre H, Hallit S, Hajj A, Sili G, Salameh P. Pharmacy Practice 2019;17(2):1438.
doi: 10.18549/pharmpract.2019.2.1438. PMID: 31275496.
Mandatory continuing education for pharmacists in a developing country: assessment of a three-year cycle
Tawil S, Sacre H, Hallit S, Sili G, Salameh P.
Pharmacy Practice 2019; 17(3):1545.
doi: 10.18549/PharmPract.2019.3.1545 10. PMID: 31592035.
Enoxaparin 20 mg for thromboprophylaxis in severe renal impairment
Tawil S, Karaoui L, Salameh P, Chamoun N.
J Int Med Res 2019;47(1):225-234.
doi: 10.1177/0300060518799896. PMID: 30259770.
Non-antistreptococcal interventions for acute guttate psoriasis or an acute guttate flare of chronic psoriasis
Maruani A, Samimi M, Stembridge N, Abdel Hay R, Tavernier E, Hughes C, Le CleachL.
Cochrane Database Syst Rev. 2019 Apr 8;4(4):CD011541
doi: 10.1002/14651858.CD011541.pub2.PMID: 30958563 Free PMC article.
Habits and risk perception associated with sun exposure in vitiligo patients according to their participation in a patients' organization
Bhatia B, Kechichian E, Eleftheriadou V, Castelneau JP, Seité S, Meurant JM, Hamzavi I, Lim H, Seneschal J,
Taieb C, Ezzedine K.
J Eur Acad Dermatol Venereol. 2019 Mar;33(3):e100-e103.
doi: 10.1111/jdv.15264. Epub 2018 Oct 17. PMID: 30284740 No abstract available.
GENIPSO: a French prospective study assessing instantaneous prevalence, clinical features and impact on quality of life of genital psoriasis among patients consulting for psoriasis
Larsabal M, Ly S, Sbidian E, Moyal-Barracco M, Dauendorffer JN, Dupin N, Richard MA, Chosidow O, Beylot-Barry M.
Br J Dermatol. 2019 Mar;180(3):647-656.
doi: 10.1111/bjd.17147. Epub 2018 Nov 1. PMID: 30188572.
Antistreptococcal interventions for guttate and chronic plaque psoriasis
Dupire G, Droitcourt C, Hughes C, Le CleachL.
Cochrane Database Syst Rev. 2019 Mar 5;3(3):CD011571.
doi: 10.1002/14651858.CD011571.pub2.PMID: 30835819 Free PMC article.
Burden of severe spondyloarthritis in France: A nationwide assessment of prevalence, associated comorbidities and cost
Claudepierre P, Fagnani F, Cukierman G, de Chalus T, Joubert JM, Laurendeau C, Gourmelen J, Breban M.
Joint BoneSpine. 2019 Jan;86(1):69-75.
doi: 10.1016/j.jbspin.2018.04.003. Epub 2018 Apr 27. PMID: 29709699.
The impact of atopic dermatitis on sexual health
Misery L, Seneschal J, Reguiai Z, Merhand S, Héas S, Huet F, Taieb C, Ezzedine K.
J Eur Acad Dermatol Venereol. 2019 Feb;33(2):428-432.
doi: 10.1111/jdv.15223. Epub 2018 Sep 23. PMID: 30160809.
Persistence of treatment with biologics for patients with psoriasis: a real-world analysis of 16 545 biologic-naïve patients from the French National Health Insurance database (SNIIRAM)
Sbidian E, Mezzarobba M, Weill A, Coste J, Rudant J.
Br J Dermatol. 2019 Jan;180(1):86-93.
oi: 10.1111/bjd.16809. Epub 2018 Sep 23. PMID: 29791721.
Association between IL23R and ERAP1 polymorphisms and sacroiliac or spinal MRI inflammation in spondyloarthritis: DESIR cohort data
Ruyssen-Witrand A, Luxembourger C, Cantagrel A, Nigon D, Claudepierre P, Degboe Y, Constantin A.
Arthritis Res Ther. 2019 Jan 15;21(1):22.
doi: 10.1186/s13075-018-1807-5. PMID: 30646942 Free PMC article. Clinical Trial.
Evaluation of extreme patient-reported outcome in early spondyloarthritis and its impact on the effect of TNF-α blockers treatment
Meghnathi B, Claudepierre P, Dougados M, Moltó A.
Clin Exp Rheumatol. 2018 Nov-Dec;36(6):1043-1048. Epub 2018 Aug 29.
PMID: 30183594.
Which scoring method depicts spinal radiographic damage in early axial spondyloarthritis best? Five-year results from the DESIR cohort
Ramiro S, Claudepierre P, Sepriano A, van Lunteren M, Molto A, Feydy A, Antonietta d'Agostino M, Loeuille D, Dougados M, Reijnierse M, van der Heijde D.
Rheumatology (Oxford). 2018 Nov 1;57(11):1991-2000.
doi: 10.1093/rheumatology/key185. PMID: 30053219.
Psoriatic arthritis screening by the dermatologist: development and first validation of the 'PURE-4 scale'
Audureau E, Roux F, Lons Danic D, Bagot M, Cantagrel A, Dernis E, Gouyette N, Hilliquin P, Jullien D, Lioté F,
Passeron T, A Richard M, Claudepierre P.
J Eur Acad Dermatol Venereol. 2018 Nov;32(11):1950-1953.
doi: 10.1111/jdv.14861. Epub 2018 Mar 9. PMID: 29430720.
The impact of psoriasis on professional life: PsoPRO, a French national survey
Claudepierre P, Lahfa M, Levy P, Barnetche T, Bonnet I, Aubert R, Roquelaure Y.
J Eur Acad Dermatol Venereol. 2018 Oct;32(10):1702-1709.
doi: 10.1111/jdv.14986. Epub 2018 May 9. PMID: 29633363.
The relationship between hypovitaminosis D and metabolic syndrome: a cross sectional study among employees of a private university in Lebanon
Samar Merhi & Jessy El Hayek Fares, Rachelle Ghadieh, Jocelyne Mattar Bou Mosleh, Sibelle Al Hayek.
BMC Nutrition.
doi: 10.1186/s40795-018-0243-x . PMID: 32153897.
Burden of albinism: development and validation of a burden assessment tool
Morice-Picard F, Taïeb C, Marti A, Gliksohn A, Bennani M, Bodemer C, Ezzedine K.
Filière Maladies Rares en Dermatologie: FIMARAD. Orphanet J Rare Dis. 2018 Sep 18;13(1):162.
doi: 10.1186/s13023-018-0894-3. PMID: 30227882 Free PMC article.
Association Between Mediterranean Anti-inflammatory Dietary Profile and Severity of Psoriasis: Results From the NutriNet-Santé Cohort
Phan C, Touvier M, Kesse-Guyot E, Adjibade M, Hercberg S, Wolkenstein P, Chosidow O, Ezzedine K, Sbidian E.
JAMA Dermatol. 2018 Sep 1;154(9):1017-1024.
doi: 10.1001/jamadermatol.2018.2127. PMID: 30046840 Free PMC article.
Pain Management in Two Tertiary-Care Hospitals: Patients Satisfaction and Related Barriers
Tawil S, Iskandar K, Salameh P.
Pharmacy practice 2018; 16(3), 1268.
doi: 10.18549/PharmPract.2018.03.1268. PMID: 30416629.
Can power Doppler ultrasound of the entheses help in classifying recent axial spondyloarthritis? Data from the DESIR cohort
Poulain C, D'Agostino MA, Thibault S, Daures JP, Ferkal S, Le Corvoisier P, Rahmouni A, Loeuille D, Dougados M, Claudepierre P.
RMD Open. 2018 Aug 22;4(2):e000686.
doi: 10.1136/rmdopen-2018-000686. eCollection 2018. PMID: 30167327 Free PMC article.
Trends in hospitalization rates for psoriasis flares since the introduction of biologics: a time series in France between 2005 and 2015
Polivka L, Oubaya N, Bachelez H, Paul C, Richard MA, Beylot-Barry M, Schmutz JL, Beneton N, Mahé E, Viguier M,
Chosidow O, Canoui-Poitrine F, Sbidian E.
Groupe de Recherche sur le Psoriasis de la Société Française de Dermatologie. J Eur Acad Dermatol Venereol. 2018 Nov;32(11):1920-1929.
doi: 10.1111/jdv.15044. Epub 2018 May 31. PMID: 29729123.
2018 update of French Society for Rheumatology (SFR) recommendations about the everyday management of patients with spondyloarthritis
Wendling D, Lukas C, Prati C, Claudepierre P, Gossec L, Goupille P, Hudry C, Miceli-Richard C, Molto A,
Pham T, Saraux A, Dougados M.
Joint Bone Spine. 2018 May;85(3):275-284.
doi: 10.1016/j.jbspin.2018.01.006. Epub 2018 Mar 8. PMID: 29407043 Review.